Pharmafile Logo

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Photo of Jon in Cuttsy+Cuttsy branded shapes

Over the last two decades, Jon has gained extensive experience in agency commercial roles, client services, and strategy. He has worked closely with senior client stakeholders, building successful relationships, developing key accounts, creating new products, and scaling agency teams. Alongside his comprehensive healthcare experience, Jon also enriches C+C with his expertise in digital and FMCG sectors.

In 2020, Jon was honoured in the BIMA 100 list as one of the leaders, pioneers, entrepreneurs, and changemakers leading the digital sector, recognising his achievements in building and leading agency client services and project management teams.

Caroline Benson, Co-Founder, says, “Having worked with Jon over the last year, he is already a valued member of the C+C family. We are thrilled he has joined the team in a full-time capacity.”

Mathew Cutts adds, “For the last four years, we have been strengthening our leadership team in line with our growth. Jon joins us to help continue our growth plans and contribute to keeping the business aligned with ever-changing technologies, while remaining true to our ‘people first’ value.”

Jon Hume expresses, “After closely collaborating with C+C and their fantastic clients throughout most of 2023, I am privileged to take the next step and join this talented team. Their work significantly impacts patient lives every day, and I am eager to contribute.”

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

The digital prescription – enhancing the patient experience with technology

We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters…

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Clinical trial considerations: Why digital matters…

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Clinical trials explained: Why imagery matters…

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Clinical trials explained: Why health literacy matters…

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...